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Aims. Our previous experiments revealed an association of PTPIP51 (protein tyrosine phosphatase interacting protein 51) with
the insulin signalling pathway through PTP1B and 14-3-3beta. We aimed to clarify the role of PTPIP51 in adipocyte metabolism.
Methods. Four groups of ten C57Bl/6mice each were used. Two groups were fed a standard diet; two groups were fed a high-fat diet.
Two groups (one high-fat diet and one standard diet) were submitted to endurance training, while the remaining two groups served
as untrained control groups. After ten weeks, we measured glucose tolerance of the mice. Adipose tissue samples were analyzed by
immunofluorescence and Duolink proximity ligation assay to quantify interactions of PTPIP51 with either insulin receptor (IR) or
PKA. Results. PTPIP51 and the IR and PTPIP51 and PKA, respectively, were colocalized in all groups. Standard diet animals that
were submitted to endurance training showed low PTPIP51-IR and PTPIP51-PKA interactions. The interaction levels of both the
IR and PKA differed between the feeding and training groups. Conclusion. PTPIP51 might serve as a linking protein in adipocyte
metabolism by connecting the IR-triggered lipogenesis with the PKA-dependent lipolysis. PTPIP51 interacts with both proteins,
therefore being a potential gateway for the cooperation of both pathways.
1. Introduction
Obesity abets several life style diseases such as diabetes
type II, atherosclerosis, or impaired wound healing. These
adverse effects can be avoided or, if already present, reduced
by physical activity. Physical activity increases sympathetic
activity and blood catecholamine levels. Adaption to peri-
odic physical exercise is well studied. Exercise training and
increased catecholamine levels affect adipocyte metabolism,
on one hand by influencing insulin secretion [1] and on
the other hand by additionally channelling the adipocyte
metabolism towards lipolysis [2]. This effect is mediated by
beta2-adrenergic receptors which activate the intracellular
adenylyl cyclase. Adenylyl cyclase transforms ATP into cyclic
AMP (cAMP), which in turn increases the activity level of
cAMP-dependent protein kinase A (PKA) [3, 4]. Protein
kinase A thereupon initiates lipolysis [4].
Themost potent antagonist of catecholamines on adipose
tissue is insulin. Activation of the insulin receptor results in
decreased lipolysis, increased lipogenesis and uptake of fatty
acids.
Lipolysis is decreased by insulin-receptor-induced
phosphodiesterase-3B (PDE-3B) and 14-3-3beta-dependent
reduction of PKA activity [3, 5]. Furthermore, the insulin
receptor activates several lipogenic enzymes by tyrosine
phosphorylation and promotes GLUT-4 recruitment to the
cell membrane [6].
Protein tyrosine phosphatase interacting protein 51
(PTPIP51) is expressed in different organs with a multitude
of functions [7, 8]. As previously shown for mouse adipose
tissue, PTPIP51 acts as an effector in insulin signalling.
PTPIP51 expressionwas correlated to the insulin resistance of
the animals [9], according to the expression of its interaction
partner protein tyrosine phosphatase 1B (PTP1B). In addition
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Table 1: Energy content of standard diet and high-fat diet.
Values in kcal/100 g Standard diet High-fat diet
Protein 24 20
Carbohydrates 65 35
Fat 11 45
to that, PTPIP51 is connected to the lipolytic MAPK pathway
by its interaction with raf-1 mediated by 14-3-3beta [7]. 14-
3-3beta also interacts with phosphodiesterase 3B, resulting
in reduced intracellular cAMP levels and decreased PKA
activity [9]. As 14-3-3beta and PTP1B are important for
adipocyte metabolism control, the role of its interaction
partner PTPIP51 needs to be disclosed.
The interaction of PTPIP51 with the insulin receptor and
PKA was investigated in adipose tissue from animals kept
under different defined experimental conditions to search for
a potential role of PTPIP51 in adipocyte metabolism.
2. Material and Methods
2.1. Study Design. The experiments were performed with
male C57Bl/6 mice (𝑛 = 40) and approved by the local
Animal Care and Use Committee (Gi 20/24 Nr. 94/2010).The
animals were kept under standard conditions (12 h light/dark
cycle) with no access to running wheels. They were fed ad
libitum with free access to water. The animals were aged
ten weeks at the beginning of the training. The experiments
were run for 14 weeks, with a four-week period of fat feeding
followed by a ten-week training period.
Control group (SD): the animals were fed a standard diet
(Altromin standard diet no. 1324, Altromin, Lage, Germany).
Endurance training control group (SDT): the animals
were fed a standard diet (Altromin standard diet no. 1324,
Altromin, Lage, Germany) and trained for a period of ten
weeks. The training was performed on a motorized treadmill
for 35min/day at 12m/min, at 12% grade, 5 times per week,
for ten weeks. Running speed was 0.27m/s ± 0.05m/s
corresponding to 80% of maximal oxygen consumption.
High-fat-diet group (HFD): the animals were fed a high-
fat diet containing 45% fat for 14 weeks of the experimental
period.
High-fat-diet, training group (HFDT): The animals were
fed a high-fat-diet during the complete experimental time
period. The endurance training period started four weeks
after the beginning of high-fat-diet feeding and was similar
to the training described above.
For diet composition, see Table 1.
After 14weeks, the animals were sacrificed in themorning
between 10 and 12 o’clock and the abdominal adipose tissue
was frozen in liquid nitrogen precooled isopentan, and
transferred to −80∘C till further analysis. See also Bobrich et
al. [9]. A glucose tolerance test was performed to determine
the insulin sensitivity of the mice [9–11]. For testing the
glucose tolerance of the animals, they were injected intraperi-
toneally with 2 g of 20% D-glucose dissolved in sterile 0.9%
NaCl solution per kg body weight. The blood was collected
and glucose concentration was determined. The test was
performed in the morning; last feeding of the animals took
place the previous day.
2.2. PTPIP51 Antibody Production. An antibody against a
defined peptide sequence at the C-terminus of PTPIP51
(sequence: IQKDLEELEVILRD, exon 13) was produced
(BioLux, Stuttgart, Germany). Identity and purity of the syn-
thesized peptide were approved by ESI-MS and UV-analysis.
Rabbits were immunized with the KLH-conjugated peptide.
The specificity of the antibody was tested by ELISA and
Western blot. Preabsorption experiments were performed
[9, 12].
2.3. Immunofluorescence. Immunofluorescence staining was
performed according to a standard protocol [9].The primary
PTPIP51 antibody to the C-terminus was used in 1 : 800
dilutions and visualized by Alexa 555 (Molecular Probes,
Darmstadt, Germany, Cat. no. A21428). Primary monoclonal
mouse antibodies were used for double staining experiments
with PKA (ab58187, Abcam plc, 330 Cambridge Science
Park, Cambridge, UK) and the beta-subunit of the IR (clone
CT-3, Millipore, 28820 Single Oak Drive, Temecula, CA,
USA). To avoid unspecific binding of the primary mouse
antibodies, samples were preincubated with biotin-coupled
anti-mouse-antibodies for one hour. The reaction of the
primary monoclonal mouse antibody was visualized using
Alexa fluor 488 secondary antibodies (Molecular Probes,
Darmstadt, Germany, Cat. no. A11001).
2.4. Confocal Laser Scanning Microscopy. Confocal images
of cells were obtained with a Leica confocal laser scanning
microscope (CLSM, 5 TCS SP2, Leica, Bensheim, Germany).
Confocal images of Alexa Fluor 555 fluorescence were
acquired using 6 Plan-Apochromat × 40/1.4 oil objective,
548 nm excitation wavelengths (helium-neon laser), and a
560–585 nm band-pass filter. The pinhole diameter was set
to yield optical sections of 1 airy unit. For the detection of
Alexa Fluor 488, we used a Plan-Apochromat × 40/1.4 oil
objective, the 488 nm excitation wavelength of an argon laser,
and a 505–530 nm band-pass filter. The pinhole diameter
was set to yield optical sections of 1 Airy unit. Confocal
images of To-Pro-3 fluorescence (Molecular probes, Cat.
no. T3605) (nuclear staining) were acquired using Plan-
Apochromat × 40/1.4 oil objective, 633 nm excitation wave-
lengths (helium-neon laser), and the 650–670 nm bandpass
filter.The pinhole diameter was set to yield optical sections of
1 Airy unit. AcquiredDIC and confocal images were analyzed
and combined using the LCS software (Leica Confocal
Software).
Acquired images were subsequently processed by ImageJ
(v1.43m; Rasband, W.S., ImageJ, US National Institutes
of Health, Bethesda, MD, USA, http://imagej.nih.gov/ij/,
1997–2011) using an iterative deconvolution plug-in by Bob
Dougherty (http://www.optinav.com/imagej.html, Iterative
Deconvolution). Options were set for all confocal acquired
images as follows: 8 numbers of iteration and 2.0 pixels
of LP filter diameter. Point spread function was calculated
for each channel separately by the ImageJ plug-in created
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Figure 1:The principle of the Duolink proximity ligation assay. (a) Binding of primary antibodies to PTPIP51 and the IR or PKA. (b) Binding
of secondary antibodies, PLA probe PLUS and PLA probe MINUS. (c) Connector oligos only hybridize if both proteins are closer than
40 nm. (d) Ligation of the complex forms a circular template. (e) Rolling circle amplification. (f) Amplification yields a some hundredfold
replication, and added fluorophore labelled probes highlight the reaction, resulting in a point-shaped signal. Figure 1 is a reproduction of the
Olink instruction manual by courtsey of Olink Bioscience.
by Bob Dougherty (http://www.optinav.com/imagej.html,
Diffraction Limit PSF).
2.5. Intensity Correlation Analysis. Intensity correlation anal-
ysis (ICA) was carried out using ImageJ (v1.43m; Rasband,
W.S., ImageJ, US National Institutes of Health, Bethesda,
MD,USA, http://imagej.nih.gov/ij/, 1997–2011) and an appro-
priate plug-in for ICA included in the plug-in package
of the Wright cell imaging facility [13] (http://www.uhnres
.utoronto.ca/facilities/wcif/fdownload.html).
2.6. Duolink Proximity Ligation Assay (DPLA). Interaction
of PTPIP51 with either PKA or beta-subunit of the IR was
detected by the proximity ligation assay kit Duolink (Olink
|Bioscience, Uppsala, Sweden, PLA probe anti-rabbit minus
for the detection of the rabbit PTPIP51 antibody, Cat. no.
90602; PLA probe anti-mouse PLUS for the detection of the
mouse anti PKA or IR antibody, Cat. no. 90701; Detection Kit
563, Cat. no. 90134).
The DPLA was performed according to the manufac-
turer’s protocol; negative controls were included [9, 14, 15].
For the principle of the DPLA, see Figure 1.
2.7. Fluorescence Microscopy. The Axioplan 2 fluorescence
microscope equippedwith Plan-Apochromat objectives (Carl
Zeiss Jena, Germany) was used for photo documentation. For
visualization of theDPLA, an excitation filter with a spectrum
of 530–560 nm and an emission filter with a spectrum of 572–
647 nm were used.
2.8. Analysis of Duolink Proximity Ligation Assay Results. The
Duolink Image Tool (Olink biosciences, Uppsala, Sweden)
was used for quantification of the detected DPLA signals. All
analyzed sections were investigated with equal light intensity
and shutter speed. Sensitivity of the software scan and blob
threshold were set identically for all probes. The positive
reaction dots were counted automatically.
2.9. Database Research. We accomplished a database
research using the GPS 2.1 database [16] to identify kinases
within adipocyte metabolism that possess the ability to
phosphorylate PTPIP51.
2.10. Statistical Analysis. The observed data were analysed by
nonparametrical tests to determine the significance of the
results.
3. Results
3.1. Glucose Tolerance Test and Mean Body Weight. The
glucose tolerance was determined by a standard glucose
tolerance test at the end of the experimental period. SD and
SDT animals displayed a slight increase of blood glucose
levels 30 minutes after application of glucose which was
almost normalized after 60 minutes.
In HFD animals, blood glucose levels strongly increased
from the basal level of 100mg/dL to 400mg/dL 60 minutes
after application. Blood glucose levels did not return to
normal values within 120 minutes.
In HFDT animals, blood glucose levels increased to
270mg/dL 30 minutes after application and almost returned
to normal values after 120 minutes (Figure 2). The values
of HFD, HFDT, and animals fed a standard diet (SD and
SDT) are significantly different after 30 and 60minutes. After
120 minutes, the differences between standard diet and high
fat diet animals remained significant, whereas there was no
significant difference between standard diet and trained high-
fat-diet animals.
Mean body weight was measured at different time points
throughout the test (see Table 2).
Statistical analysis showed that there was no significant
difference between the four groups at 10 weeks of age. From
the beginning of the training, the difference between standard
diet and high-fat-diet-fed groups was highly significant, but
there was no significant difference between the SD and SDT
and, respectively HFD and HFDT groups.
3.2. PTPIP51 Protein Is Colocalized with the Insulin Receptor
(IR) and Protein Kinase A (PKA). PTPIP51 localization in
adipose tissue did not differ between the four experimental
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Figure 2: Glucose tolerance test: average of blood glucose con-
centrations in mg/dL after intraperitoneal application of glucose
solution. Blood glucose levels were determined 0, 30, 60, and 120
minutes after application. Glucose tolerance is inversely related to
insulin resistance. SD standard diet group (𝑛 = 10), SDT standard
diet and training group (𝑛 = 10), HFD: high-fat-diet group (𝑛 = 10),
HFDT: high-fat-diet and training group (𝑛 = 10).
setups. PTPIP51 immunoreactivity was detected within the
cytoplasm and at the plasma membrane (Figure 3).
The IR revealed a similar expression pattern when com-
pared to PTPIP51. In the cytoplasm, the immune reaction
of the IR antibody was lower compared to PTPIP51. The
computed data of the intensity correlation analysis is dis-
played in Figure 3(B). Colocalization is displayed in yellow
to orange and noncolocalized parts are shown in blue. Most
colocalization was detected at the plasma membrane.
PKA is also colocalizedwith PTPIP51, especially concern-
ing its expression in the cytoplasm. The computed data of
the intensity correlation analysis is displayed in Figure 3(D).
Co-localization is displayed in yellow to orange and non-co-
localized parts are shown in blue. Most colocalization was
detected within the cytoplasm.
3.3. PTPIP51 and IR Interact and the Interaction Depends
on the Feeding Status. The Duolink proximity ligation assay
(DPLA) was performed to detect interactions between
PTPIP51 and the beta-subunit of the IR. The interaction of
PTPIP51 and IR was verified as seen in Figure 4, where each
dot indicates the interaction of both proteins.This interaction
of PTPIP51 and the IR was found in the adipocytes of animals
from all experimental groups. Specificity of the DPLA was
tested (Figure 4).
The grade of interaction in adipose samples from SD
animals corresponds to the level in HFDT animals. A
decrease in the interaction was detected in samples from SDT
animals. HFD animals displayed the highest interaction level
(Figure 5(a)).
3.4. Interaction between PTPIP51 and PKADisplayed aDepen-
dency on Training Status. The Duolink proximity ligation
Table 2: Mean body weight in grams with standard deviation.
Basic value (10
weeks of age)
Beginning of
training (14
weeks of age)
End of test
period (24
weeks of age)
Standard diet
(SD) 23.22 ± 2.41 23.16 ± 1.03 27.74 ± 0.96
Standard diet
and training
(SDT) 22.81 ± 3.11 22.79 ± 0.77 26.54 ± 1.15
High fat diet
(HFD) 23.67 ± 3.02 40.37 ± 2.97 50.91 ± 2.56
High fat diet
and training
(HFDT) 23.44 ± 2.88 42.22 ± 3.18 49.23 ± 3.43
assay was performed to detect interactions between PTPIP51
and PKA. The assumption of an interaction of PTPIP51 and
PKA based on the database research was verified (Figure 4).
PTPIP51 and PKA were interacting in adipocytes of animals
from all experimental groups.
The interaction levels of SD, HFD, and HFDT mice did
not show significant differences. The interaction levels seen
in SDT mice were decreased (Figure 5(b)).
4. Discussion
To sum up the results, adipocytes from mice subjected to
different diets and activity levels displayed a connection
between PTPIP51 and the insulin receptor, and PTPIP51 and
PKA respectively. Animals of the four experimental groups
displayed differences in their glucose resistance.The glucose-
tolerance test revealed a glucose-intolerant status in HFD
and HFDT animals, whereas the glucose tolerance of HFDT
animals improved compared to HFD animals.
Immunofluorescence data displayed colocalization of
PTPIP51 with IR and PKA suggesting an interaction between
PTPIP51 and IR, and PTPIP51 and PKA respectively. Basing
on these facts, we performed a GPS 2.1 database research.
Search results displayed PTPIP51 to be phosphorylated at
tyrosine 176 by the insulin receptor and at serine 46 by PKA
[16]. These two phosphorylation sites are possible regulatory
sites for the interaction of PTPIP51 with 14-3-3beta, thus
being able to influence the MAPK pathway by interaction
with raf-1 [17]. Phosphorylation of Serine 46 in PTPIP51
results in augmented interaction with raf-1 via 14-3-3 and
thus in increased ERK1/2 phosphorylation, promoting the
MAPK pathway [12, 17]. The MAPK pathway is suspected
to possess two opposite functions in adipocytes. Depending
on the activator, ERK1/2 conveys either adipocyte growth or
lipolysis [18]. PKA is known to induce lipolysis through the
MAPK pathway [18, 19].
The insulin receptor induces tyrosine phosphorylation of
PTPIP51 at tyrosine 176, which leads to reduced interaction
of PTPIP51 with 14-3-3beta and raf-1 [20], thereby decreasing
the MAPK pathway activity.
Journal of Obesity 5
Figure 3: Immunostaining of PTPIP51, insulin receptor, andPKA in adipocytes of standard diet animals. (A) Immunostaining of PTPIP51 and
the insulin receptor. (B) Intensity correlation of PTPIP51 and the insulin receptor, high correlation is displayed in yellow. (C) Immunostaining
of PTPIP51 and PKA. (D) Intensity correlation of PTPIP51 and the insulin receptor, high correlation is displayed in yellow; Bar (A): 60 𝜇m;
Bar (C): 15𝜇m.
Analysis of the PTPIP51 interaction profile of adipocytes
displayed high interaction levels with the insulin receptor in
HFD animals. Interaction levels were reduced by 30% in SD
and HFDT and by 50% in SDT animals, compared to HFD
animals.
High-fat feeding increases the lipogenic activity in adi-
pose tissue [21, 22]. This is consistent with our observation
of high interaction levels in HFD animals. Training leads to
reduced adipocyte size [23]. The reduced PTPIP51-IR inter-
action in trained groups compared to the corresponding
untrained groups suggests that PTPIP51 is especially involved
in the processes of insulin induced lipogenesis or in its
antilipolytic action.
Interaction levels between PTPIP51 and PKA did not
show significant differences in SD, HFD, and HFDT animals.
In SDT animals, the interaction was reduced.
The low interaction in SDT animals seems to be contro-
versial. But, as PKA also interacts with the hormone-sensitive
lipase (HSL), a change of the interaction partner of PKA away
from PTPIP51 under these preconditions is assumable. The
interaction between PKA and HSL is a potent promoter for
lipolysis in adipocytes. The activities of both PKA and HSL
are increased in endurance-trained animals [24, 25].
Our experiments suggest that PTPIP51 could mediate
between lipogenesis and lipolysis by switching between the
lipogenic insulin pathway and the lipolytic PKA pathway.
Further experiments need to be conducted in order to prove
our hypothesis and to determine the magnitude in which
PTPIP51 engages in adipocyte metabolism.
Abbreviations
PKA: cAMP-activated protein kinase A
DPLA: Duolink proximity ligation assay
HFD: High fat-diet
HFDT: High-fat diet and training
HSL: Hormone-sensitive lipase
IR: Insulin receptor
MAPK: Mitogen-activated protein kinase
PDE-3B: Phosphodiesterase-3B
PTPIP51: Protein tyrosine phosphatase
interacting protein 51
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Figure 4: Duolink proximity ligation assay to detect interactions between PTPIP51 and the insulin receptor (IR), respectively PTPIP51 and
PKA in standard diet animals. (A) Interaction between PTPIP51 and the IR. (B) Interaction between PTPIP51 and PKA. (C) Negative control,
PTPIP51 and the IR in testis, no interaction known. (D) Negative control, DPLA without primary antibodies in adipose tissue. Nuclei are
marked by DAPI staining. Arrows: positive reactions. Bars (A, B): 50 𝜇m. Bars (C, D): 20𝜇m.
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Figure 5: Semiquantitative analysis of the interaction between PTPIP51 and its interaction with IR and with PKA. Every section was
subdivided into rectangles of the same size and dots were counted.The results were averaged for each section. (a) Semiquantitative evaluation
of PTPIP51 interaction with IR. (b) Semiquantitative evaluation of PTPIP51 interaction with PKA. SD: standard diet group. SDT: standard
diet and training group. HFD: high-fat-diet group. HFDT: high-fat-diet and training group.
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